Skip to main content
. 2013 Oct 25;8(10):e77694. doi: 10.1371/journal.pone.0077694

Figure 2. Forest plot(s) comparing NOACs and warfarin in AF patients with previous stroke or TIA, for stroke (A), disabling and fatal stroke(B), stroke and systemic embolism (C), hemorrhagic stroke (D), and all-cause mortality (E).

Figure 2